Feed 0512.HK
05
Grand Pharmaceutical Group Limited
0512.HK · HKSE
$5.23 -1.78% (-$0.10)
1M +1.55%
Market Cap $18.7B
P/E Ratio 15.04x
Div. Yield 3.17%
ROE 7.48%
Bulios Fair Price
$4.72
9.8% downside
Current Price
$5.23
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 0512.HK is currently overvalued relative to its market price. How does it work?
Valuation
76 /100
Cheap P/E 15.04x
EV/EBITDA 9.62x
P/S 1.52x
Growth
52 /100
Stable EPS growth 15.98%
Rev. growth 8.71%
FCF growth 46.60%
Profitability
58 /100
Moderate Gross margin 55.20%
Net margin 10.10%
Op. margin 8.49%
Quality
29 /100
Poor ROIC 3.82%
ROE 7.48%
ROA 4.57%
Debt
81 /100
Low Debt/Equity 0.28x
Current ratio 1.14x
Int. coverage 10.88x
Stability
85 /100
Stable Beta 0.70x
Rev. volatility 2.82%
EPS volatility 39.83%
Ask StockBot about 0512.HK
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Chao Zhou
Employees
12,614
Headquarters
Hong Kong
Upcoming events
26 AUG
Earnings
Upcoming earnings report